Monotherapy or combination therapy w/ interferon for treatment of chronic hepatitis B. Combination therapy w/ interferon for treatment of chronic hepatitis C. Adjuvant for flu vaccination in immunocompromised patients. Adjuvant therapy for chemotherapy-induced immune depression, immune insufficiency & immune suppression in NSCLC, malignant melanoma, hepatocellular carcinoma (HCC), breast cancer, non-Hodgkin's lymphoma (CHOP program), CRC, head & neck cancer, leukemia's pancreatic carcinoma & renal cell carcinoma.
SCChronic hepatitis B 1.6 mg twice a wk for 6-12 mth. Patients <40 kg 40 mcg/kg. Chronic hepatitis C 1.6 mg twice a wk for 12 mth. Patients <40 kg 40 mcg/kg. Vaccine adjuvant 1.6 mg SC twice a wk w/ doses separated by 3 or 4 days & 1st dose given coincident w/ the vaccine. Single-dose regimen: 4 wk. Multidose regimen: Twice a wk for 3 wk (a total of 5-6 doses) after the last vaccination. Cancer 1.6 mg using various schedules for 6 mth or given between chemotherapy cycles.
Sign Out
